Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Communications
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. nature communications
  3. articles
  4. article
Routine blood tests and machine learning identify complications in high myopia
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 14 March 2026

Routine blood tests and machine learning identify complications in high myopia

  • Shengjie Li  ORCID: orcid.org/0000-0002-6443-740X1,2,3,4 na1,
  • Jun Ren1 na1,
  • Fenglin Wang5,
  • Jianing Wu1,
  • Yingzhu Li1,
  • Xuanxuan Wang6,
  • Mengyu Zhang7,
  • Henggui Hu7,
  • Yunxiao Song8,
  • Wenjun Cao  ORCID: orcid.org/0000-0001-6383-90121,2,3,4,
  • Xingtao Zhou  ORCID: orcid.org/0000-0002-3465-15792,3,4 &
  • …
  • Meiyan Li  ORCID: orcid.org/0000-0003-3702-09802,3,4 

Nature Communications , Article number:  (2026) Cite this article

  • 5591 Accesses

  • 18 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Eye diseases
  • Machine learning
  • Predictive markers

Abstract

High myopia can lead to cataract, glaucoma, retinal detachment, choroidal neovascularisation, and macular degeneration, causing irreversible vision loss. Imaging detects these complications, but population screening is limited by equipment, and specialist availability. Here we show that a machine learning model using routine blood test results identifies people at increased risk of complications related to high myopia during standard health examinations. We develop the model in a multicentre study of 10,661 participants and validate it in two independent cohorts. The model shows high accuracy across centres (area under the receiver operating characteristic curve=0.9010-0.9649) and flags individuals who receive a clinical diagnosis in a hospital-based prospective follow-up study of 5,067 participants. In a community screening study of 311,254 adults, the model increases the yield of detected complications among those referred for ophthalmic assessment (positive predictive value = 74%). This scalable blood-based approach supports opportunistic screening and earlier referral in primary care and community settings.

Similar content being viewed by others

CCL2-mediated inflammatory pathogenesis underlies high myopia-related anxiety

Article Open access 12 September 2023

Eye disease and mortality, cognition, disease, and modifiable risk factors: an umbrella review of meta-analyses of observational studies

Article 16 July 2021

Predicting onset of myopic refractive error in children using machine learning on routine pediatric eye examinations only

Article Open access 17 August 2025

Data availability

The de-identified data of the discovery cohort and validation cohort in this study have been deposited in the Source data file. The corresponding acronyms for these cohorts are listed in Tables S1 and S2, respectively. Access to comprehensive, individual-level clinical data is restricted to protect participant privacy and comply with the conditions of informed consent. The individual-level clinical data may be made available upon request to the corresponding author, accompanied by a study protocol and evidence of ethical approval. All requests will be reviewed by the corresponding author (Meiyan Li) in consultation with the cohort leadership and relevant study committees, and a response is typically provided within 12 weeks. Approved users will be required to sign a Data Use Agreement specifying that the data are to be used solely for the approved project and that any resulting publications must acknowledge the data source. The data will be made available only for scientific research purposes. Once access has been granted, the data will remain available for six months. The data generated in this study are provided in the Supplementary Information/Source Data file. Source data are provided with this paper.

Code availability

The analysis code was written in Python (version 3.11) and relies on standard open-source libraries (NumPy, Pandas, scikit-learn, XGBoost), used in compliance with their MIT and BSD licences. All reused components retain their original license and attribution. The analysis codes are available on GitHub at (https://github.com/fudanRenjun/high-myopia/tree/master) archived with Zenodo66 under https://doi.org/10.5281/zenodo.18382509.

References

  1. Flitcroft, D. I. et al. IMI - defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest. Ophthalmol. Vis. Sci. 60, M20–M30 (2019).

    Google Scholar 

  2. Morgan, I. G., Ohno-Matsui, K. & Saw, S.-M. Myopia. Lancet 379, 1739–1748 (2012).

    Google Scholar 

  3. Zhang, X. et al. Optic neuropathy in high myopia: glaucoma or high myopia or both?. Prog. Retin. Eye Res. 99, 101246 (2024).

    Google Scholar 

  4. Flitcroft, D. I. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog. Retin. Eye Res. 31, 622–660 (2012).

    Google Scholar 

  5. Kanthan, G. L., Mitchell, P., Rochtchina, E., Cumming, R. G. & Wang, J. J. Myopia and the long-term incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Clin. Exp. Ophthalmol. 42, 347–353 (2014).

    Google Scholar 

  6. Haarman, A. E. G. et al. The complications of myopia: a review and meta-analysis. Invest. Ophthalmol. Vis. Sci. 61, 49 (2020).

    Google Scholar 

  7. Wang, Y. X. et al. High myopia as risk factor for the 10-year incidence of open-angle glaucoma in the Beijing Eye Study. Br. J. Ophthalmol. 107, 935–940 (2023).

    Google Scholar 

  8. Du, Y. et al. Complications of high myopia: an update from clinical manifestations to underlying mechanisms. Adv. Ophthalmol. Pract. Res. 4, 156–163 (2024).

    Google Scholar 

  9. Foo, L. L. et al. Predictors of myopic macular degeneration in a 12-year longitudinal study of Singapore adults with myopia. Br. J. Ophthalmol. 107, 1363–1368 (2023).

    Google Scholar 

  10. Zheng, F. et al. Quantitative OCT angiography of the retinal microvasculature and choriocapillaris in highly myopic eyes with myopic macular degeneration. Br. J. Ophthalmol. 106, 681–688 (2022).

    Google Scholar 

  11. Liu, H. et al. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis. Lancet Glob. Health 11, e456–e465 (2023).

    Google Scholar 

  12. Fricke, T. R. et al. Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling. Br. J. Ophthalmol. 102, 855–862 (2018).

    Google Scholar 

  13. World Health Organization. World report on vision. Geneva: World Health Organization; 2019. Available from: https://www.who.int/publications/i/item/9789241516570

  14. Cheung, N. et al. Prevalence and associations of retinal emboli with ethnicity, stroke, and renal disease in a multiethnic Asian population: the Singapore Epidemiology of Eye Disease Study. JAMA Ophthalmol. 135, 1023–1028 (2017).

    Google Scholar 

  15. Igarashi-Yokoi, T. et al. Prognostic factors for axial length elongation and posterior staphyloma in adults with high myopia: a Japanese Observational Study. Am. J. Ophthalmol. 225, 76–85 (2021).

    Google Scholar 

  16. Chen, Y. et al. Acceptability, applicability, and cost-utility of artificial-intelligence-powered low-cost portable fundus camera for diabetic retinopathy screening in primary health care settings. Diab. Res. Clin. Pract. 223, 112161 (2025).

    Google Scholar 

  17. Ahn, S. J. & Kim, Y. H. Clinical applications and future directions of smartphone fundus imaging. Diagnostics 14, 1395 (2024).

    Google Scholar 

  18. Li, S. et al. Developing and validating a clinlabomics-based machine-learning model for early detection of retinal detachment in patients with high myopia. J. Transl. Med. 22, 405 (2024).

    Google Scholar 

  19. Li, S. et al. Development and validation of a routine blood parameters-based model for screening the occurrence of retinal detachment in high myopia in the context of PPPM. EPMA J. 14, 219–233 (2023).

    Google Scholar 

  20. Perais, J. et al. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. Cochrane Database Syst. Rev. 2, CD013775 (2023).

    Google Scholar 

  21. Li, S. et al. Association between 17-β-estradiol and interleukin-8 and visual field progression in postmenopausal women with primary angle closure glaucoma. Am. J. Ophthalmol. 217, 55–67 (2020).

    Google Scholar 

  22. Horton, S. et al. The Top 25 laboratory tests by volume and revenue in five different countries. Am. J. Clin. Pathol. 151, 446–451 (2019).

    Google Scholar 

  23. Foy, B. H. et al. Haematological setpoints are a stable and patient-specific deep phenotype. Nature 637, 430–438 (2025).

    Google Scholar 

  24. Lundberg, S. M. et al. From local explanations to global understanding with explainable AI for trees. Nat. Mach. Intell. 2, 56–67 (2020).

    Google Scholar 

  25. Bossi, E. et al. Revolutionizing blood collection: innovations, applications, and the potential of microsampling technologies for monitoring metabolites and lipids. Metabolites 14, 46 (2024).

    Google Scholar 

  26. Gause, W. C., Wynn, T. A. & Allen, J. E. Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat. Rev. Immunol. 13, 607–614 (2013).

    Google Scholar 

  27. Rosenberg, H. F., Dyer, K. D. & Foster, P. S. Eosinophils: changing perspectives in health and disease. Nat. Rev. Immunol. 13, 9–22 (2013).

    Google Scholar 

  28. Nishiguchi, K. M. et al. C9-R95X polymorphism in patients with neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 53, 508–512 (2012).

    Google Scholar 

  29. Leung, D. Y. M. et al. Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin. J. Allergy Clin. Immunol. Pract. 11, 1421–1428 (2023).

    Google Scholar 

  30. Gao, L., Jiang, W., Liu, H., Chen, Z. & Lin, Y. Receptor-selective interleukin-4 mutein attenuates laser-induced choroidal neovascularization through the regulation of macrophage polarization in mice. Exp. Ther. Med. 22, 1367 (2021).

    Google Scholar 

  31. Ames, B. N., Cathcart, R., Schwiers, E. & Hochstein, P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA 78, 6858–6862 (1981).

    Google Scholar 

  32. van Leeuwen, E. M. et al. A new perspective on lipid research in age-related macular degeneration. Prog. Retin Eye Res. 67, 56–86 (2018).

    Google Scholar 

  33. Li, B., Goss, D., Miller, J. W., Lin, J. B. & Vavvas, D. G. Systemic dyslipidemia in age-related macular degeneration: an updated systematic review and meta-analysis. Ophthalmol. Sci. 4, 100341 (2024).

    Google Scholar 

  34. Ma, Y., Li, S., Shao, M., Cao, W. & Sun, X. Platelet parameters and their relationships with the thickness of the retinal nerve fiber layer and ganglion cell complex in primary open-angle glaucoma. Front. Neurol. 13, 867465 (2022).

    Google Scholar 

  35. Qiu, J. et al. Development and validation of a multimodal multitask vision foundation model for generalist ophthalmic artificial intelligence. NEJM AI https://doi.org/10.1056/AIoa2300221 (2024).

  36. Babenko, B. et al. A deep learning model for novel systemic biomarkers in photographs of the external eye: a retrospective study. Lancet Digit. Health 5, e257–e264 (2023).

    Google Scholar 

  37. Wang, J. et al. Artificial intelligence-enhanced retinal imaging as a biomarker for systemic diseases. Theranostics 15, 3223–3233 (2025).

    Google Scholar 

  38. Xiao, W. et al. Screening and identifying hepatobiliary diseases through deep learning using ocular images: a prospective, multicentre study. Lancet Digit. Health 3, e88–e97 (2021).

    Google Scholar 

  39. Mitani, A. et al. Detection of anaemia from retinal fundus images via deep learning. Nat. Biomed. Eng. 4, 18–27 (2020).

    Google Scholar 

  40. Joo, Y. S. et al. Non-invasive chronic kidney disease risk stratification tool derived from retina-based deep learning and clinical factors. NPJ Digit. Med. 6, 114 (2023).

    Google Scholar 

  41. Cheung, C. Y. et al. A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel calibre. Nat. Biomed. Eng. 5, 498–508 (2021).

    Google Scholar 

  42. Zhang, L. et al. Prediction of hypertension, hyperglycemia and dyslipidemia from retinal fundus photographs via deep learning: a cross-sectional study of chronic diseases in central China. PLoS ONE 15, e0233166 (2020).

    Google Scholar 

  43. Rajalakshmi, R., Prathiba, V., Arulmalar, S. & Usha, M. Review of retinal cameras for global coverage of diabetic retinopathy screening. Eye 35, 162–172 (2021).

    Google Scholar 

  44. Peng, Y. et al. Eye care use among rural adults in China: the Handan Eye Study. Ophthalmic Epidemiol. 20, 274–280 (2013).

    Google Scholar 

  45. Liang, Y. B. et al. Refractive errors in a rural Chinese adult population the Handan eye study. Ophthalmology 116, 2119–2127 (2009).

    Google Scholar 

  46. Li, S. et al. A noninvasive machine learning model using a complete blood count for screening of primary vitreoretinal lymphoma. Nat. Commun. 16, 10667 (2025).

    Google Scholar 

  47. Li, S. et al. Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression. eLife 12, RP91407 (2024).

    Google Scholar 

  48. Li, S. et al. Serum metabolite biomarkers for the early diagnosis and monitoring of age-related macular degeneration. J. Adv. Res. S2090-1232, 00434–X (2024).

    Google Scholar 

  49. Long, Q., Ye, J., Li, Y., Wang, S. & Jiang, Y. C-reactive protein and complement components in patients with pathological myopia. Optom. Vis. Sci. 90, 501–506 (2013).

    Google Scholar 

  50. Arndt, C. et al. Increased intravitreal glucose in rhegmatogenous retinal detachment. Eye 37, 638–643 (2023).

    Google Scholar 

  51. Luo, S. et al. Quantitative proteomics analysis of human vitreous in rhegmatogenous retinal detachment associated with choroidal detachment by data-independent acquisition mass spectrometry. Mol. Cell. Biochem. 477, 1849–1863 (2022).

    Google Scholar 

  52. Li, S. et al. Association of systemic inflammation indices with visual field loss progression in patients with primary angle-closure glaucoma: potential biomarkers for 3P medical approaches. EPMA J. 12, 659–675 (2021).

    Google Scholar 

  53. Li, S. et al. Association between coagulation function and patients with primary angle closure glaucoma: a 5-year retrospective case-control study. BMJ Open 7, e016719 (2017).

    Google Scholar 

  54. Shao, M., Li, Y., Teng, J., Li, S. & Cao, W. Association between serum lipid levels and patients with primary angle-closure glaucoma in china: a cross sectional, case-control study. Front. Med.) 8, 618970 (2021).

    Google Scholar 

  55. Shao, M. et al. Association between serum complement C3 levels and age-related cataract. Invest. Ophthalmol. Vis. Sci. 58, 4934–4939 (2017).

    Google Scholar 

  56. Li, S. et al. Association between serum lipids concentration and patients with age-related cataract in China: a cross-sectional, case-control study. BMJ Open 8, e021496 (2018).

    Google Scholar 

  57. Li, B. et al. Predictive role of the peripheral blood inflammation indices neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immunoinflammatory index (SII) for age-related cataract risk. PLoS ONE 19, e0313503 (2024).

    Google Scholar 

  58. Wang, Y. et al. The association between the lipids levels in blood and risk of age-related macular degeneration. Nutrients 8, 663 (2016).

    Google Scholar 

  59. Pinna, A. et al. Complete blood cell count-derived inflammation biomarkers in men with age-related macular degeneration. Ocul. Immunol. Inflamm. 27, 932–936 (2019).

    Google Scholar 

  60. Berkelmans, G. F. N. et al. Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice. J. Clin. Epidemiol. 145, 70–80 (2022).

    Google Scholar 

  61. Grandini, M., Bagli, E. & Visani, G. Metrics for multi-class classification: an overview. Preprint at https://doi.org/10.48550/arXiv.2008.05756 (2020).

  62. Hanley, J. A. & McNeil, B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29–36 (1982).

    Google Scholar 

  63. Kerr, K. F., Brown, M. D., Zhu, K. & Janes, H. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J. Clin. Oncol. 34, 2534–2540 (2016).

    Google Scholar 

  64. Steyerberg, E. W. et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21, 128–138 (2010).

    Google Scholar 

  65. Hu, J. et al. Identification and validation of an explainable prediction model of acute kidney injury with prognostic implications in critically ill children: a prospective multicenter cohort study. EClinicalMedicine 68, 102409 (2024).

    Google Scholar 

  66. fudanRenjun. fudanRenjun/high-myopia: high-myopia. Zenodo https://doi.org/10.5281/zenodo.18382509 (2026).

Download references

Acknowledgements

This work was supported by the National Key Research and Development Program of China (2024YFC2510805, X.T.Z.), Shanghai Municipal Health Commission (2023ZZ02019, X.T.Z.), and the National Natural Science Foundation of China (82302582, S.J.L.). The sponsors or funding organisations played no role in the design or execution of this research. We gratefully acknowledge the Putuo District Central Hospital of Shanghai University for providing the sample data used in this study.

Author information

Author notes
  1. These authors contributed equally: Shengjie Li, Jun Ren.

Authors and Affiliations

  1. Department of Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai, China

    Shengjie Li, Jun Ren, Jianing Wu, Yingzhu Li & Wenjun Cao

  2. Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China

    Shengjie Li, Wenjun Cao, Xingtao Zhou & Meiyan Li

  3. NHC Key laboratory of Myopia and Related Eye Diseases; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, China

    Shengjie Li, Wenjun Cao, Xingtao Zhou & Meiyan Li

  4. Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China

    Shengjie Li, Wenjun Cao, Xingtao Zhou & Meiyan Li

  5. College of Life Sciences, Nankai University, Tianjin, China

    Fenglin Wang

  6. Department of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Anhui, China

    Xuanxuan Wang

  7. Department of Clinical Laboratory, Anhui Wanbei Electricity Group General Hospital, Suzhou, China

    Mengyu Zhang & Henggui Hu

  8. Department of Clinical Laboratory, Shanghai Xuhui Central Hospital, Fudan University, Shanghai, China

    Yunxiao Song

Authors
  1. Shengjie Li
    View author publications

    Search author on:PubMed Google Scholar

  2. Jun Ren
    View author publications

    Search author on:PubMed Google Scholar

  3. Fenglin Wang
    View author publications

    Search author on:PubMed Google Scholar

  4. Jianing Wu
    View author publications

    Search author on:PubMed Google Scholar

  5. Yingzhu Li
    View author publications

    Search author on:PubMed Google Scholar

  6. Xuanxuan Wang
    View author publications

    Search author on:PubMed Google Scholar

  7. Mengyu Zhang
    View author publications

    Search author on:PubMed Google Scholar

  8. Henggui Hu
    View author publications

    Search author on:PubMed Google Scholar

  9. Yunxiao Song
    View author publications

    Search author on:PubMed Google Scholar

  10. Wenjun Cao
    View author publications

    Search author on:PubMed Google Scholar

  11. Xingtao Zhou
    View author publications

    Search author on:PubMed Google Scholar

  12. Meiyan Li
    View author publications

    Search author on:PubMed Google Scholar

Contributions

W.J.C., X.T.Z, M.Y.L. and S.J.L. conceptualised and designed this study. S.J.L., Y.Z.L., J.N.W., F.L.W., X.X.W., M.Y.Z., H.G.H., Y.X.S. and J.R. performed most experiments. W.J.C., X.T.Z. and M.Y.L. performed partial experiments. S.J.L., J.N.W., F.L.W. and J.R. finished the acquisition and analysis of data. S.J.L., J.R., F.L.W. and J.N.W. prepared figures and performed the statistical analysis. S.J.L. wrote the original draft. W.J.C., X.T.Z, M.Y.L. and S.J.L. reviewed and supervised the manuscript. All the authors have read and approved the final manuscript.

Corresponding authors

Correspondence to Shengjie Li, Wenjun Cao, Xingtao Zhou or Meiyan Li.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Communications thanks Mengtian Kang, Carla Lança and the other anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information (download PDF )

Peer Review file (download PDF )

Reporting Summary (download PDF )

Source data

Source Data (download XLSX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, S., Ren, J., Wang, F. et al. Routine blood tests and machine learning identify complications in high myopia. Nat Commun (2026). https://doi.org/10.1038/s41467-026-70891-5

Download citation

  • Received: 04 June 2025

  • Accepted: 08 March 2026

  • Published: 14 March 2026

  • DOI: https://doi.org/10.1038/s41467-026-70891-5

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Editors
  • Journal Information
  • Open Access Fees and Funding
  • Calls for Papers
  • Editorial Values Statement
  • Journal Metrics
  • Editors' Highlights
  • Contact
  • Editorial policies
  • Top Articles

Publish with us

  • For authors
  • For Reviewers
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Communications (Nat Commun)

ISSN 2041-1723 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing